Phillip Musselman’s expert witnesses weren’t able to connect his anxiety, insomnia, paranoia, and other symptoms to his use of a 300-milligram dose of the antidepressant bupropion, instead of the 150-dose his doctor intended to be used first, the Minnesota Court of Appeals said in an unpublished opinion.
Musselman couldn’t have won at trial because he lacked ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.